Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries
Niklas Worm Andersson, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study
Siyue Jia, Zundong Yin, Hongxing Pan, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 10
Viral sepsis-induced mortality of older patients infected by the Omicron subvariant BA.5 of SARS-CoV-2: a retrospective study
Yu Zhang, Jiaxin Li, Chenglei Su, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
COVID-19 Vaccine Effectiveness Among Adolescents
Eero Poukka, Niklas Worm Andersson, Emilia Myrup Thiesson, et al.
PEDIATRICS (2024) Vol. 153, Iss. 2
Closed Access | Times Cited: 3
Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case–control study, United Kingdom, 2022
Anastasia Chatzilena, Catherine Hyams, Robert Challen, et al.
Eurosurveillance (2023) Vol. 28, Iss. 48
Open Access | Times Cited: 8
Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data
Niklas Worm Andersson, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001074-e001074
Open Access | Times Cited: 2
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice
Sue Ann Costa Clemens, Lily Yin Weckx, Eveline Pı́polo Milan, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3989-3998
Open Access | Times Cited: 1
Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives
Yu-An Kung, Chih-Hsien Chuang, Yi-Ching Chen, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 1
A Letter to the Editor Regarding ‘Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework’
Hannah R. Volkman, Jennifer L. Nguyen, Luis Jódar, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2203-2206
Open Access | Times Cited: 1
Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection
Yu Lei, Nansong Xu, Chuanying Niu, et al.
Virology (2024) Vol. 597, pp. 110142-110142
Closed Access | Times Cited: 1
Why older adults can continue to benefit from covid-19 boosters
Kristine Macartney
BMJ (2023), pp. p1662-p1662
Open Access | Times Cited: 3
COVID -19: On the threshold of the fifth year. The situation in Spain
Fernando Rodrı́guez-Artalejo, Julián Ruiz‐Galiana, Rafael Cantón, et al.
Revista Española de Quimioterapia (2023) Vol. 37, Iss. 1, pp. 17-28
Open Access | Times Cited: 3
Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron
Ángel Paternina‐Caicedo, David Santiago Quevedo, Diana Sofía Rios, et al.
Journal of Infection (2024) Vol. 88, Iss. 6, pp. 106165-106165
Open Access
Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022–2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants
J Horváth, Gergő Túri, Katalin Krisztalovics, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 496-496
Open Access
Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia
Awatef Ben Jemaa, Rihab Bouabsa, Meriam Ben Othmen, et al.
La Tunisie Médicale (2024) Vol. 102, Iss. 8
Closed Access
A Response to: A Letter to the Editor Regarding ‘Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework’
Ekkehard Beck, Mary T. Bausch-Jurken, Nicolas Van de Velde, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 10, pp. 2195-2202
Open Access
Pulmonary embolism after SARS-CoV-2 vaccination
Björn Zethelius, Sofia Attelind, Gabriel Westman, et al.
Vaccine X (2024) Vol. 21, pp. 100571-100571
Open Access
A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults
Timothy Peter Jones, Stephanie A. Harris, Hazel Morrison, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Optimizing protocols for the 919 strain-based bovine ephemeral fever virus vaccine (Ultravac®, Zoetis™): Evaluation of dose-dependent effectiveness and long-term immunity
Dan Gleser, Michal Cohen, Gabriel Kenigswald, et al.
Vaccine (2024) Vol. 43, pp. 126531-126531
Closed Access
Covid-19 boosters: improving patient information leaflets
Peter McCartney
BMJ (2023), pp. p2100-p2100
Closed Access
Page 1

Scroll to top